Global report - September 5, 2014
GE Healthcare gets EU approval of VIZAMYL
VIZAMYL has received marketing authorisation from the European Commission for PET imaging of beta amyloid plaque in suspected Alzheimer’s disease. It will be commercially available in selected European countries from early 2015. When used in conjunction with a clinical evaluation, using VIZAMYL to detect the accumulation of beta amyloid in the brain may help to confirm an Alzheimer’s […]
Acquisition - September 5, 2014
ProstaLund acquires NMT
The acquisition of NMT, Nordisk Medicin & Teknik AB, a medtech agency company that markets and sells urology products, will cost ProstaLund approximately SEK 4 million. Buying NMT will complete ProstaLund’s current product portfolio and increase the corporate group’s revenues with SEK 5 million on an annual basis, states ProstaLund. The acquisition is part of […]
Pharma Business - September 5, 2014
Meda divests US unit
Meda has signed an agreement to divest the manufacturing unit in Lakewood, New Jersey. The manufacturing unit will be divested to the contract manufacturer DPT. According to Meda the manufacturing facility is dedicated to global supply of the product MUSE. As part of the agreement Meda has entered into a long term supply agreement with DPT […]
Uncategorized - September 4, 2014
Japanese robotics firm to test in Denmark
High-tech company Fuji Machine has chosen to set up a new testing facility in Denmark. Fuji Machine has entered into a large cooperative agreement with Odense Municipality which initially includes testing of their robotic technologies within the region’s healthcare sector. The nursing staff and patients at Odense University Hospital (OUH) are currently testing Fuji Machine’s […]
MedTech Business - September 4, 2014
Norwegian order for Sectra
The major Norwegian healthcare region, Helse Vest, is investing in a digital media archive from Sectra. The total order value amounts to EUR 2 million. Sectra’s solution will be used to manage medical images and videos in the region, including images from ultrasound and endoscopy examinations. “Using Sectra’s solution, we will be able to efficiently manage […]
Intellectual Property - September 3, 2014
AstraZeneca lost patent controversy
Teva has announced that the UK High Court gives positive judgment in the company’s patent case against AstraZeneca. The case regards the validity of EP 1,085,877 covering the SMART (Single inhaler Maintenance And Reliever Therapy) indication for AstraZeneca’s fixed dose formoterol/budesonide combination product, Symbicort. Teva said that the court agreed with Teva that AstraZeneca’s patent covering […]
